Nestor Soler
Overview
Explore the profile of Nestor Soler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Crisafulli E, Sartori G, Huerta A, Gabarrus A, Fantin A, Soler N, et al.
Chest
. 2023 Jul;
164(6):1422-1433.
PMID: 37516272
Background: Recently, the Rome proposal updated the definition of exacerbation of COPD (ECOPD). However, such severity grade has not yet demonstrated intermediate-term clinical relevance. Research Question: What is the association...
3.
Fernandez-Pittol M, Batista-Arnau S, Roman A, Nicolas L, Oliver L, Gonzalez-Moreno O, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671265
: It has been suggested that , , and have differential drug susceptibility patterns. We prospectively analyzed and compared the drug susceptibility patterns among these species over an 8.5-year period....
4.
Gonzalez-Torralba F, Baloira A, Abad A, Fuster A, Garcia-Rivero J, Garcia-Sidro P, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 May;
17:1005-1015.
PMID: 35547784
Purpose: The pharmacological treatment of chronic obstructive pulmonary disease (COPD) is largely based on inhaled bronchodilators. Inspiratory flow and lung deposition are key parameters to be considered in inhaled therapy;...
5.
Cilloniz C, Torres A, Garcia-Vidal C, Moreno-Garcia E, Amaro R, Soler N, et al.
Arch Bronconeumol
. 2021 Oct;
57:79-82.
PMID: 34629674
No abstract available.
6.
Baloira A, Abad A, Fuster A, Garcia Rivero J, Garcia-Sidro P, Marquez-Martin E, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Apr;
16:1021-1033.
PMID: 33907390
Background: Our aim was to describe: 1) lung deposition and inspiratory flow rate; 2) main characteristics of inhaler devices in chronic obstructive pulmonary disease (COPD). Methods: A systematic literature review...
7.
Crisafulli E, Manco A, Guerrero M, Ceccato A, Huerta A, Gabarrus A, et al.
Intern Emerg Med
. 2020 Jul;
16(2):401-408.
PMID: 32638204
Methods: this observational prospective study considered hospitalized AECOPD patients. Three groups were created according to tertiles of age distribution: group 1 (≤ 67 years), group 2 (68-76 years) and group...
8.
Casanova G, Amaro R, Soler N, Sanchez M, Badia J, Barbera J, et al.
Eur Respir J
. 2019 Dec;
55(2).
PMID: 31806720
No abstract available.
9.
Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrus A, et al.
Respir Res
. 2018 Dec;
19(1):261.
PMID: 30591055
Background: Chronic obstructive pulmonary disease (COPD) patients may experience an acute exacerbation (AECOPD) that requires hospitalisation. The length of hospital stay (LHS) has a great economic impact on the health-care...
10.
Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrus A, et al.
Sci Rep
. 2018 Jun;
8(1):9236.
PMID: 29915333
The coexistence of both Chronic Obstructive Pulmonary Disease (COPD) and bronchiectasis (BE) define an emerging phenotype with a worse prognosis; however, data about these patients do not consider baseline characteristics...